CD8A and melanoma: In addition, a lipid-based nanoparticle containing a poly I:C–imiquimod complex showed excellent efficacy against a melanoma tumor model by triggering a protective immune response via LN-resident DCs provoking robust tumor-specific CD8+ T cell responses [58].